U.S. Markets close in 3 hrs 50 mins

Ultragenyx: 2Q Earnings Snapshot

NOVATO, Calif. (AP) _ Ultragenyx Pharmaceutical Inc. (RARE) on Thursday reported a loss of $52.7 million in its second quarter.

The Novato, California-based company said it had a loss of $1.06 per share. Losses, adjusted for non-recurring gains, were $1.87 per share.

The results topped Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of $2.10 per share.

The biotechnology company posted revenue of $12.8 million in the period, also beating Street forecasts. Nine analysts surveyed by Zacks expected $4.6 million.

Ultragenyx shares have risen 72 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $79.58, a climb of 27 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RARE at https://www.zacks.com/ap/RARE